INGN (STOCKS)
Inogen Inc
$6.450000
+0.120000 (+1.90%)
Prev close: $6.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Kevin R. M. Smith
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $175.10M
- Employees
- 766
- P/E (TTM)
- -7.39
- P/B (TTM)
- 0.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.26 | $-0.36 | +0.1046 | +28.69% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.22 | +0.0944 | +42.07% |
|
Jun 2025 (Q2)
|
$-0.15 | $-0.27 | +0.1220 | +44.85% |
|
Mar 2025 (Q1)
|
$-0.25 | $-0.51 | +0.2575 | +50.74% |
Financial Statements
| Revenues | $348.67M |
| Benefits Costs and Expenses | $372.05M |
| Cost Of Revenue | $194.40M |
| Costs And Expenses | $372.05M |
| Gross Profit | $154.27M |
| Nonoperating Income/Loss | $6.83M |
| Operating Expenses | $184.47M |
| Depreciation and Amortization | $15.74M |
| Research and Development | $19.40M |
| Other Operating Expenses | $149.33M |
| Operating Income/Loss | -$30.21M |
| Income/Loss From Continuing Operations After Tax | -$22.75M |
| Income/Loss From Continuing Operations Before Tax | -$23.38M |
| Income Tax Expense/Benefit | -$632.00K |
| Income Tax Expense/Benefit, Current | $406.00K |
| Income Tax Expense/Benefit, Deferred | -$1.10M |
| Net Income/Loss | -$22.75M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.75M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.75M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.86 |
| Diluted Earnings Per Share | -$0.86 |
| Basic Average Shares | 26,601,652 |
| Diluted Average Shares | 26,601,652 |
| Assets | $298.63M |
| Current Assets | $198.30M |
| Inventory | $25.97M |
| Other Current Assets | $172.33M |
| Noncurrent Assets | $100.33M |
| Fixed Assets | $36.36M |
| Other Non-current Assets | $63.96M |
| Liabilities | $106.39M |
| Current Liabilities | $63.54M |
| Accounts Payable | $20.26M |
| Wages | $10.63M |
| Other Current Liabilities | $32.64M |
| Noncurrent Liabilities | $42.86M |
| Equity | $192.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $192.23M |
| Liabilities And Equity | $298.63M |
| Net Cash Flow From Operating Activities | -$11.22M |
| Net Cash Flow From Operating Activities, Continuing | -$11.22M |
| Net Cash Flow From Investing Activities | -$26.21M |
| Net Cash Flow From Investing Activities, Continuing | -$26.21M |
| Net Cash Flow From Financing Activities | $24.18M |
| Net Cash Flow From Financing Activities, Continuing | $24.18M |
| Net Cash Flow | -$13.24M |
| Net Cash Flow, Continuing | -$13.24M |
| Comprehensive Income/Loss | -$17.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$17.00M |
| Other Comprehensive Income/Loss | -$17.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $5.74M |